Skip to main content

MJFF Publications

1401 - 1410 of 7730 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • RESTRICTED
    Title: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Table for One
    Journal Name: Brain & Life
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nnn.0000856280.92010.9b
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism
    Journal Name: Pharmacological Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.phrs.2022.106338
    Citation Count: 4
  • RESTRICTED
    Title: The frontostriatal subtype of mild cognitive impairment in Parkinson's disease, but not the posterior cortical one, is associated with specific EEG alterations
    Journal Name: Cortex
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.cortex.2022.04.015
    Citation Count: 1
  • RESTRICTED
    Title: What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?
    Journal Name: Ageing Research Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.arr.2022.101648
    Citation Count: 11
  • RESTRICTED
    Title: Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.3791/63313
    Citation Count: 0
  • RESTRICTED
    Title: Evaluation of the PREDIGT score’s performance in identifying newly diagnosed Parkinson’s patients without motor examination
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00360-5
    Citation Count: 2
  • RESTRICTED
    Title: Movement disorders of the mouth: a review of the common phenomenologies
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00415-022-11299-1
    Best OA location URL:
    Citation Count: 5
  • RESTRICTED
    Title: Neurofilament light levels predict clinical progression and death in multiple system atrophy
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awac253
    Citation Count: 20
  • RESTRICTED
    Title: Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-022-00388-y
    Citation Count: 2
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.